Facebook Twitter LinkedIn Google Plus RSS

Par Pharmaceutical names new chief operating officer

By

Woodcliff Lake-based Par Pharmaceutical Companies Inc. announced Tuesday the appointment of Terrance J. Coughlin as its new chief operating officer.

According to the announcement, Coughlin will be responsible for the company’s global manufacturing activities, research and development efforts, and new product selection.

He most recently was president and CEO at Glenmark Generics Inc. USA/Glenmark Generics Limited, Par announced in a recent press release.

ALSO ON NJBIZ:

California company Terra Tech setting up infrastructure in anticipation of N.J. marijuana legalization

N.J. gives Tesla two more weeks to comply with dealer regulations

Most-read March 31: When shouldn't you file a property tax appeal?

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!